StockSelector.com
  Research, Select, & Monitor Monday, April 23, 2018 1:15:51 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ironwood Pharmaceuticals, Inc.$17.28($.29)(1.65%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Ironwood Pharmaceuticals, Inc. vs Chemicals - Major Diversified

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.




Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $298.3 Mil $96,060.6 Mil
  Market Cap: $2,599.8 Mil $202,453.4 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
 Growth
  Historic Revenue: 8.9% .7%
  Estimated Revenue: 33.0% 16.7%
  Historic Earnings: N/A 3.3%
  Estimated Earnings: N/A 18.8%
  Stock Price (1 Year): 7.6% 18.2%
  Cash per Share: 127.7% 53.3%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 108.0 16.4
  Price-to-Sales: 8.7 N/A
  Price-to-Book: 264.2 3.9
  Dividend Yield: N/A N/A
  Market Cap: $2,599.8 Mil $25,306.7 Mil
  Operations
  Net Margin: (39.2%) 14.6%
  Gross Margin: 93.6% 36.5%
  Return on Equity: (11.9) .2
  Return on Assets: (.2) .1
  Balance Sheet
  Current Ratio: 4.7 1.7
  Quick Ratio: 4.7 1.2
  Cash Ratio: 3.4 .4
  Debt-to-Equity: 60.5 1.9
  Interest Coverage: (.1) .5
 Technicals
  Relative-Strength Index: 61.2 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $25.70 $54,866.0 Mil
  Praxair, Inc.  (PX) $150.68 $43,141.2 Mil
  Air Products & Chemicals, Inc.  (APD) $166.27 $36,240.2 Mil
  Akzo Nobel N.V.  (AKZOY) $32.11 $24,285.8 Mil
  Eastman Chemical Company  (EMN) $107.34 $15,428.0 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.